Page last updated: 2024-09-04

edotreotide and Cancer of Prostate

edotreotide has been researched along with Cancer of Prostate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Bokhari, TH; Hassan, M; Khosa, MK; Lodhi, NA; Usman, M1
Götz, TI; Kuwert, T; Lang, EW; Maier, A; Ritt, P; Schmidkonz, C1
Bombardieri, E; Bonacina, M; Ghirardelli, P; Setti, L; Vavassori, V1
Essler, M; Krause, BJ; Maurer, T; Souvatzoglou, M; Treiber, U; Weirich, G1

Reviews

1 review(s) available for edotreotide and Cancer of Prostate

ArticleYear
A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes.
    Chemical biology & drug design, 2023, Volume: 102, Issue:5

    Topics: Actinium; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals

2023

Other Studies

3 other study(ies) available for edotreotide and Cancer of Prostate

ArticleYear
Particle filter de-noising of voxel-specific time-activity-curves in personalized
    Zeitschrift fur medizinische Physik, 2020, Volume: 30, Issue:2

    Topics: Female; Humans; Lutein; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Radiopharmaceuticals; Signal-To-Noise Ratio; Single Photon Emission Computed Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon

2020
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:2

    Topics: Adenocarcinoma; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Octreotide; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms

2022
68Ga-DOTATOC-PET/CT detects neuroendocrine differentiation of prostate cancer metastases.
    Nuklearmedizin. Nuclear medicine, 2009, Volume: 48, Issue:5

    Topics: Anilides; Antineoplastic Agents; Cell Differentiation; Cisplatin; Etoposide; Humans; Male; Middle Aged; Nitriles; Octreotide; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Tosyl Compounds

2009